Growth signals Target medical device and life science manufacturers looking for contract manufacturing, packaging, and sterilization services, as LSO has expanded through acquisitions and asset investments including J-Pac Medical and strategic manufacturing assets.

Leadership change capitalize on the recent CEO appointment and CFO history to approach C-suite buyers at growth-oriented medtech firms, offering scalable outsourcing partnerships with strong governance and traceability.

Operational strengths Leverage LSO's end-to-end services including sterilization validation, complete lot traceability and device history records to pitch as a compliance-driven partner to manufacturers seeking validated, auditable manufacturing support.

Geographic/scale fit Position to mid-to-large medtech players looking to outsource manufacturing, packaging, and sterilization at scale, using LSO’s 201-500 employee base and California operations as a regional capability with potential for geographic expansion.

Tech and trust Highlight the company’s ISO 13485 certification and traceability systems as differentiators in quality, risk management, and regulatory alignment, appealing to risk-averse manufacturers prioritizing compliance.